Jailall Ramnauth

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Neuraxon, Inc., Affinium Pharmaceuticals, Inc., Debiopharm International, S.a.. Active years: 2005-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jailall Ramnauth. Retrieved from https://idiyas.com/inventor/jailall-ramnauth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 29.4

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 76(Granted Patents)

Location History:

Toronto, CA (2005 - 2010)
Brampton, CA (2008 - 2018)

Company Filing History:

Affinium Pharmaceuticals, Inc.

patents

2 out of 22

Debiopharm International, S.a.

patents

4. 1 out of 38

Avanir Pharmaceuticals

patents

Years Active: 2005-2018

Loading Chart...

Areas of Expertise:

Fab I Inhibitors

Indole Compounds

NOS Inhibitory Activity

Acrylamide Derivatives

Benzothiazines

Phenyl-Indole Compounds

Therapeutic Agents

Heterocyclic Compounds

Tricyclic Compounds

Prodrugs

Polymorphs

Cellular Proliferation

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9862737 - Salts, prodrugs and polymorphs of fab I inhibitors (2018-01-09),

2. 8895545 - Acrylamide derivatives as Fab I inhibitors (2014-11-25),

3. 8673909 - Indole compounds and methods for treating visceral pain (2014-03-18),

4. 8618286 - Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity (2013-12-31),

5. 8586620 - Substituted indole compounds having NOS inhibitory activity (2013-11-19),

6. 8450307 - Therapeutic agents, and methods of making and using the same (2013-05-28),

7. 8318720 - Acrylamide derivatives as Fab I inhibitors (2012-11-27),

8. 8263613 - Salts, prodrugs and polymorphs of fab I inhibitors (2012-09-11),

9. 8173813 - Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity (2012-05-08),

10. 8106043 - Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity (2012-01-31),

11. 7989447 - 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity (2011-08-02),

12. 7951940 - Substituted indole compounds having NOS inhibitory activity (2011-05-31),

13. 7790709 - Heterocyclic compounds, methods of making them and their use in therapy (2010-09-07),

14. 7375219 - Substituted indole compounds having NOS inhibitory activity (2008-05-20),

15. 7375118 - Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation (2008-05-20),

Title: The Innovative Contributions of Jailall Ramnauth

Introduction

Jailall Ramnauth is a prominent inventor based in Brampton, Canada, known for his significant contributions to the field of antibacterial compounds. With a total of 17 patents to his name, he has made remarkable strides in the development of innovative pharmaceutical solutions.

Latest Patents

Among his latest patents are "Salts, prodrugs and polymorphs of Fab I inhibitors," which focuses on antibacterial compounds and their salts. Another notable patent is "Acrylamide derivatives as Fab I inhibitors," which also pertains to the development of antibacterial compounds. These inventions highlight his commitment to advancing medical science and improving health outcomes.

Career Highlights

Throughout his career, Jailall has worked with several reputable companies, including Neuraxon, Inc. and Affinium Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Jailall has collaborated with talented individuals such as Shawn Maddaford and Suman Rakhit, further enhancing his innovative capabilities and expanding his professional network.

Conclusion

Jailall Ramnauth's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect his dedication to developing effective antibacterial solutions that can significantly impact public health.

Profile summary based on public USPTO records.